Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions on all aspects of the most recent research on human cancers. This section lies at the interface between medicinal chemistry and oncology research. We encourage the submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. The scope of this section includes, but is not limited to, the following:
- Biological processes like gene activity and metabolisms in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular pathology and immunology in tumor development
- Biomarkers in diagnostic processes
- Novel therapies like drug therapy, radiotherapy, gene therapy, hormonal therapy, and immunotherapy
- Cancer vaccines
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in the Molecular Basis of BRCA-Associated Cancers (Deadline: 29 April 2021)
- Epigenetic Regulation of Stem Cells and Cancer (Deadline: 30 April 2021)
- Cancer Stem Cells in Basic Science and in Translational Oncology (Deadline: 30 April 2021)
- Molecular Alterations in GastroIntestinal Pre-invasive Lesions (Deadline: 30 April 2021)
- Genetic Basis and Molecular Mechanisms of Uveal Melanomas (Deadline: 30 April 2021)
- Epigenetic Modifications and Carcinogenesis (Deadline: 30 April 2021)
- Cancer Chemoprevention: New Knowledge (Deadline: 30 April 2021)
- Extracellular Matrix in the Tumor Microenvironment (Deadline: 30 April 2021)
- Advances in Spine Oncology (Deadline: 30 April 2021)
- PSMA in Prostate Cancer (Deadline: 30 April 2021)
- Proteases: Role and Function in Cancer (Deadline: 30 April 2021)
- Molecular Research on Chronic Myeloid Leukemia (Deadline: 30 April 2021)
- Advances in Cancer Metabolism and Tumour Microenvironment (Deadline: 30 April 2021)
- Immunotherapy for Hematological and Solid Cancers (Deadline: 30 April 2021)
- MicroRNA/Long Non Coding RNA Networking in Cancer Therapeutics and Diagnostics (Deadline: 5 May 2021)
- Noncoding RNAs as New Instruments in the Orchestration of Cell Death and Cancer Therapy Resistance (Deadline: 15 May 2021)
- Gastrointestinal Cancers: Molecular Pathophysiology, Novel Biomarkers and Therapeutic Approaches (Deadline: 31 May 2021)
- Dichloroacetate (DCA) and Cancer: Advancing DCA to a Cancer Therapeutic (Deadline: 31 May 2021)
- Molecular Research Efforts in Urothelial Carcinoma 2.0 (Deadline: 31 May 2021)
- Recent Progress in the Development of Anticancer Prodrugs (Deadline: 31 May 2021)
- Peculiarities of Transcription Factors in Cancer for the Development of Novel Therapies (Deadline: 31 May 2021)
- Circulating Cell-Free Nucleic Acids and Cancers (Deadline: 31 May 2021)
- Novel Insights on the Molecular Bases of Hormone-Responsive Breast Cancer Biology (Deadline: 31 May 2021)
- Molecular Characteristics of Renal Cell Carcinoma (Deadline: 31 May 2021)
- Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis (Deadline: 31 May 2021)
- Molecular Research on Hereditary Cancer Syndromes (Deadline: 31 May 2021)
- Hematological Malignancies (Deadline: 31 May 2021)
- Endometrial Cancer Overview: Molecular Biology and Its Potential Clinical Application (Deadline: 31 May 2021)
- Attacking Cancer Progression and Metastasis 2.0 (Deadline: 31 May 2021)
- Liver Cancer (Deadline: 31 May 2021)
- Novel Insights into Soft Tissue Sarcoma (Deadline: 31 May 2021)
- Advances on Cancer Molecular Mechanisms and Immunotherapy (Deadline: 15 June 2021)
- The Role of Reactive Oxygen Species Responsive Signaling Pathways and MicroRNAs in Anti-cancer Therapies (Deadline: 30 June 2021)
- The Epithelial-to-Mesenchymal Transition (EMT) in Cancers (Deadline: 30 June 2021)
- Role of HIF-1 in Cancer Metabolism and Progression (Deadline: 30 June 2021)
- Precision Oncology in Non-small Cell Lung Cancer (Deadline: 30 June 2021)
- Role of the Immune Microenvironment in Multiple Myeloma (Deadline: 30 June 2021)
- Mitochondrial Targeting as an Efficient Anti-cancer Therapy (Deadline: 30 June 2021)
- Extracellular Vesicles and Tumour Microenvironment 2.0 (Deadline: 30 June 2021)
- TRAIL and Autophagy Signaling in Cancer (Deadline: 30 June 2021)
- Pharmacologic Targeting of the Tumor Microenvironment (Deadline: 30 June 2021)
- Pharmacogenomic and Pharmacogenetic Characterisation of Sarcomas (Deadline: 30 June 2021)
- Sarcoma (Deadline: 30 June 2021)
- Tumor Markers in Urological Cancers: Current Advances and Future Persepectives (Deadline: 30 June 2021)
- Exploring Lipid Metabolism in Cancer by Cellular, Metabolic, and Molecular Imaging Approaches (Deadline: 30 June 2021)
- The New Molecular Strategies under Development in Thoracic Oncology (Deadline: 30 June 2021)
- Recent Advances of Immunotherapy in Lung Cancer (Deadline: 30 June 2021)
- Plant-Based Cancer Drug Discovery: Natural Products with Anti-Cancer Activity (Deadline: 30 June 2021)
- Cancer Immunotherapy: Recent Advances and Prospects (Deadline: 30 June 2021)
- Molecular Determinants of Neuroblastoma (Deadline: 15 July 2021)
- Alternative mRNA Splicing in Physiology and Cancer (Deadline: 25 July 2021)
- Biological and Molecular Mechanisms of Resistance and Tolerance during the Course of the Neoplastic Disease (Deadline: 28 July 2021)
- Prostate Cancer: From Molecular Imaging to Immunological and Target Therapies (Deadline: 31 July 2021)
- Immunological Responses to Cancer Therapy (Deadline: 31 July 2021)
- The Mechanisms of Both Epigenetic Drugs and Epigenetic Modifiers Induced Tumor Cell Death (Deadline: 31 July 2021)
- Molecular Mechanisms and Targeted Therapies in Gastrointestinal Cancers (Deadline: 31 July 2021)
- The Emerging Role of Extracellular Vesicles in Experimental Oncology (Deadline: 31 July 2021)
- Oncogenic Signaling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities (Deadline: 31 July 2021)
- Mechanism of Cell Proliferation in Glioblastoma and Melanoma (Deadline: 31 July 2021)
- Nutrition and Cancer: Recent Advances and Future Perspectives (Deadline: 31 July 2021)
- Advances in Cancer Stem Cells (Deadline: 31 July 2021)
- Mitochondrial Metabolism in Cancer (Deadline: 31 July 2021)
- Natural Compounds with Cancer-Selective Toxicity (Deadline: 31 July 2021)
- Quo Vadis Cancer Research? On Molecular Mechanisms and Drug Discovery (Deadline: 31 July 2021)
- Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells (Deadline: 31 July 2021)
- New Prognostic and Predictive Markers in Cancer Progression 2.0 (Deadline: 31 July 2021)
- Novel Therapeutic Treatments to Target Glioblastoma Intratumoral Heterogeneity and Plasticity (Deadline: 31 July 2021)
- Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 July 2021)
- Cancer: Novel Approaches in the Discovery and Design of Targeted Therapies (Deadline: 31 July 2021)
- Circulating Molecules and Precision Medicine in Cancer (Deadline: 31 July 2021)
- Hematopoietic Stem Cells, Metabolic Regulations, and Aging (Deadline: 31 July 2021)
- Gastric Cancer: Molecular Pathways and Candidate Biomarkers 4.0 (Deadline: 31 July 2021)
- Microbiota and Cancer 2.0 (Deadline: 31 July 2021)
- Chemotherapeutic Agents in Gynecological Cancers: Drug Design, Development and Therapy (Deadline: 31 July 2021)
- Molecular Mechanisms and Therapies of Myeloid Leukaemia (Deadline: 31 July 2021)
- Thyroid Disease and Thyroid Cancer (Deadline: 31 July 2021)
- Ion Transport Mechanisms in Esophageal Epithelial Cells (Deadline: 31 July 2021)
- Immunology of Hepatocellular Carcinoma 2021 (Deadline: 31 July 2021)
- The Role of Post-translational Modifications in Chromatin and Cancer (Deadline: 31 August 2021)
- In Vivo Biomarkers for Immunotherapy Efficacy in Brain Tumours (Deadline: 31 August 2021)
- Molecular Mechanism of Anti-Inflammatory Actions of Natural Components (Deadline: 31 August 2021)
- Causalities and Regulations of Tumor Metastasis—In Memory of Professor Isaiah J. Fidler (1936–2020) (Deadline: 31 August 2021)
- Primary Intraocular Tumors–Molecular Mechanisms, Novel Therapeutic Strategies and Targets (Deadline: 31 August 2021)
- The Functional Landscape of p53 (Deadline: 31 August 2021)
- Molecular Mechanisms of Asymmetric Cell Division in Neural Development and Disease (Deadline: 31 August 2021)
- Poor-Risk and Relapsed/Refractory Testicular Germ Cell Tumor (Deadline: 31 August 2021)
- microRNA as a Biomarker in Gastroenterological Cancers (Deadline: 31 August 2021)
- Deciphering the Therapeutic Resistance of Hematologic Malignancies (Deadline: 31 August 2021)
- Radiation Biology and Molecular Radiation Oncology (Deadline: 31 August 2021)
- Novel Insights into Molecular Biology of Urological Cancers (Deadline: 31 August 2021)
- Epigenetics in Solid Tumors: The Role of DNA Methylation, Histone Modifications and Chromatin Structure (Deadline: 31 August 2021)
- Immunomodulation of Skin Cancer (Deadline: 31 August 2021)
- Cancer Prevention with Molecular Target Therapies 2.0 (Deadline: 31 August 2021)
- Telomere Homeostasis, Genomic Instability and Cancer (Deadline: 31 August 2021)
- Mitochondria and Cancer: The Giant Screen View (Deadline: 31 August 2021)
- Recent Advances in Thyroid Cancer Research (Deadline: 31 August 2021)
- Diabetes, Obesity and Cancer (Deadline: 31 August 2021)
- Recent Advances in Neuroendocrine Neoplasms Research (Deadline: 31 August 2021)
- Survival Pathways Involved in Resistance to Apoptosis in Cancer 2.0 (Deadline: 31 August 2021)
- Inflammation and Cancer 2021 (Deadline: 31 August 2021)
- Cancer Cell Reprogramming 2.0 (Deadline: 31 August 2021)
- Signaling Pathways between Cancer and Immune Cells (Deadline: 20 September 2021)
- Characterizing Colorectal Cancer: MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Carcinogenesis (Deadline: 25 September 2021)
- MicroRNAs and Long Noncoding RNAs in Tumor Microenvironment (Deadline: 30 September 2021)
- Solitary Fibrous Tumors: Diagnosis, Classification and Therapy (Deadline: 30 September 2021)
- Telomeres, Telomerase and Cancer (Deadline: 30 September 2021)
- Role of Lipids in Cancer (Deadline: 30 September 2021)
- Molecular Pathology of Triple-Negative Breast Cancer and Therapeutic Implications (Deadline: 30 September 2021)
- Lipid as a Cancer Therapeutic Target 2.0 (Deadline: 30 September 2021)
- Frontiers Research in Brain Tumors: Molecular, Histopathological and Imaging Insights (Deadline: 30 September 2021)
- Transcriptional Mechanism of Glycosyltransferase Genes Related to Cancer and Diseases (Deadline: 30 September 2021)
- Secretome and Its Maturation in Tumor Microenvironment and Metastasis (Deadline: 30 September 2021)
- Integrin Signalling in Cancer (Deadline: 30 September 2021)
- Innovation through Tradition: The Current Challenges in Cancer Treatment (Deadline: 30 September 2021)
- Advances in Immuno-oncology (Deadline: 30 September 2021)
- The Research about Microbiome and Cancer (Deadline: 30 September 2021)
- Contribution of Cancer-Targeting Drugs toward Faster Clinical Application (Deadline: 30 September 2021)
- The Research of Neutrophil (Deadline: 29 October 2021)
- Enzyme Inhibitors and Activators in Cancer Research, Therapy and Prevention (Deadline: 30 October 2021)
- Gliomas: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 31 October 2021)
- Molecular Drivers of Responsiveness to Cancer Immunotherapy (Deadline: 31 October 2021)
- Tumor Secretome in Translational Oncology (Deadline: 31 October 2021)
- Role of RNA-Binding Proteins and RNA Modifiers in Cancer: Their Molecular Interplay with MicroRNAs and Other Oncogenic RNAs (Deadline: 31 October 2021)
- Cytokines/Chemokines in Cancer Metastasis 2.0 (Deadline: 31 October 2021)
- Tumor Microenvironment in Colorectal Cancer (Deadline: 31 October 2021)
- Viruses and Cancers (Deadline: 31 October 2021)
- Advances in Molecular Genetics of Brain Tumors (Deadline: 31 October 2021)
- TGF-Beta Signaling in Glioblastoma (Deadline: 31 October 2021)
- Gynaecological Tumours and Sarcomas (Deadline: 31 October 2021)
- Precision Medicine, Pharmacogenomics and Cancer Treatment (Deadline: 31 October 2021)
- Pancreatic Fibrosis in Inflammation and Cancer (Deadline: 31 October 2021)
- Ephrin Receptors and Cancer (Deadline: 31 October 2021)
- Non-coding RNAs in Glioblastoma Multiforme (Deadline: 31 October 2021)
- Theme Issue Honoring Prof. Dr. Ludger Wessjohann’s 60th Birthday: Natural Products in Anticancer Drug Discovery (Deadline: 31 October 2021)
- Skin Cancer: State-of-the-Art (Deadline: 31 October 2021)
- Altered RNA Processing in Tumor Pathogenesis and Therapy (Deadline: 31 October 2021)
- Multiple Myeloma: Focus on Molecular and Epigenetic Aspects (Deadline: 20 November 2021)
- Signal Transduction Pathways Involved in Regulation of Normal and Tumour Cells (Deadline: 30 November 2021)
- Signaling in Melanoma 2.0 (Deadline: 30 November 2021)
- Inflammation and Gastrointestinal Cancers: Molecular Mechanisms and Therapies 2.0 (Deadline: 31 December 2021)
- Melatonin and Vitamin D: Molecular Mechanisms and Biological Function (Deadline: 31 December 2021)
- Autophagy in Cancer Progression and Therapeutics (Deadline: 31 December 2021)
- Frontiers in Molecular Biology of Brain Tumors (Deadline: 31 December 2021)
Topical Collections
Following topical collections within this section are currently open for submissions:
